Found: 1
Select item for more details and to access through your institution.
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 403, doi. 10.1007/s00432-017-2556-6
- By:
- Publication type:
- Article